Dr. Lal PathLabs Limited Stock

Equities

LALPATHLAB

INE600L01024

Healthcare Facilities & Services

Market Closed - NSE India S.E. 09:03:22 2024-04-25 am EDT 5-day change 1st Jan Change
2,331 INR +0.08% Intraday chart for Dr. Lal PathLabs Limited +0.14% -9.58%
Sales 2024 * 22.36B 268M Sales 2025 * 24.94B 299M Capitalization 194B 2.32B
Net income 2024 * 3.57B 42.84M Net income 2025 * 4.16B 49.92M EV / Sales 2024 * 8.31 x
Net cash position 2024 * 7.72B 92.72M Net cash position 2025 * 10.99B 132M EV / Sales 2025 * 7.32 x
P/E ratio 2024 *
54.5 x
P/E ratio 2025 *
46.8 x
Employees 4,048
Yield 2024 *
0.74%
Yield 2025 *
0.79%
Free-Float 43.28%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.08%
1 week+0.14%
Current month+3.00%
1 month+9.48%
3 months-3.87%
6 months-4.58%
Current year-9.58%
More quotes
1 week
2 165.80
Extreme 2165.8
2 350.00
1 month
2 146.00
Extreme 2146
2 392.45
Current year
1 943.70
Extreme 1943.7
2 662.00
1 year
1 888.10
Extreme 1888.1
2 767.10
3 years
1 762.05
Extreme 1762.05
4 245.50
5 years
955.00
Extreme 955
4 245.50
10 years
696.50
Extreme 696.5
4 245.50
More quotes
Managers TitleAgeSince
Chief Executive Officer - 16-09-30
Director of Finance/CFO - 05-12-31
Chairman 74 95-02-13
Members of the board TitleAgeSince
Director/Board Member 58 23-07-26
Director/Board Member 77 15-08-20
Chairman 74 95-02-13
More insiders
Date Price Change Volume
24-04-25 2,331 +0.08% 116 745
24-04-24 2,329 +3.53% 541,153
24-04-23 2,249 -0.58% 175,334
24-04-22 2,263 +2.42% 299,488
24-04-19 2,209 -1.58% 245,714

Delayed Quote NSE India S.E., April 25, 2024 at 09:03 am EDT

More quotes
Dr. Lal PathLabs Limited is an India-based company that is engaged in providing diagnostic and related healthcare tests and services. The Company is engaged in the business of running laboratories for carrying out pathological investigations of various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It offers a range of tests by condition, which includes allergy, diabetes, health checkups, viral infections, fever, heart diseases, hypertension, cancer, abortions, anemia, arthritis, breast cancer, diphtheria, disorder of the liver, disorders of bone, drugs of abuse, infertility, lymphoma, tuberculosis, ovarian cancer, osteoporosis, multiple sclerosis, muscular disorder, and viral infections. The Company’s subsidiaries include Paliwal Diagnostics Private Limited, Paliwal Medicare Private Limited, and Dr. Lal PathLabs Nepal Private Limited.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
2,329 INR
Average target price
2,455 INR
Spread / Average Target
+5.41%
Consensus
  1. Stock Market
  2. Equities
  3. LALPATHLAB Stock